These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16336331)

  • 1. Race-specific reference ranges of serum prostate-specific antigen levels in countries with a low incidence of prostate cancer.
    Ku JH
    BJU Int; 2006 Jan; 97(1):69-72. PubMed ID: 16336331
    [No Abstract]   [Full Text] [Related]  

  • 2. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
    Porter MP; Stanford JL; Lange PH
    Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total prostate specific antigen stability confirmed after long-term storage of serum at -80C.
    Reed AB; Ankerst DP; Leach RJ; Vipraio G; Thompson IM; Parekh DJ
    J Urol; 2008 Aug; 180(2):534-7; discussion 537-8. PubMed ID: 18550121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study.
    Metcalfe C; Patel B; Evans S; Ibrahim F; Anson K; Chinegwundoh F; Corbishley C; Dorling D; Thomas B; Gillatt D; Kirby R; Muir G; Nargund V; Popert R; Persad R; Ben-Shlomo Y;
    BJU Int; 2008 Nov; 102(10):1407-12. PubMed ID: 18540931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate-specific antigen (PSA)].
    Huland H
    Urologe A; 1995 Jul; 34(4):273-4. PubMed ID: 7545840
    [No Abstract]   [Full Text] [Related]  

  • 8. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
    Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
    Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
    Stamey TA
    BJU Int; 2004 Nov; 94(7):963-4. PubMed ID: 15541106
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
    Loeb S; Roehl KA; Nadler RB; Yu X; Catalona WJ
    J Urol; 2007 Dec; 178(6):2348-52; discussion 2352-3. PubMed ID: 17936844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen.
    Honda M; Miyagawa I
    Urology; 2005 Dec; 66(6):1320. PubMed ID: 16360475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen assay standardization bias could affect clinical decision making.
    Loeb S; Chan DW; Sokoll L; Kan D; Maggiore J; Mikolajczyk SD; Mondo DM; Griffin CR; Catalona WJ
    J Urol; 2008 Nov; 180(5):1959-62; discussion 1962-3. PubMed ID: 18801532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between total prostate specific antigen concentration and prostate specific antigen velocity.
    Yu X; Loeb S; Roehl KA; Han M; Catalona WJ
    J Urol; 2007 Apr; 177(4):1298-302; discussion 1301-2. PubMed ID: 17382716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
    Rydén L; Egevad L; Ekman P; Hellström M
    Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under diagnosis and over diagnosis of prostate cancer in a screening population with serum PSA 2 to 10 ng/ml.
    Pelzer AE; Bektic J; Akkad T; Ongarello S; Schaefer G; Schwentner C; Frauscher F; Bartsch G; Horninger W
    J Urol; 2007 Jul; 178(1):93-7; discussion 97. PubMed ID: 17499288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer incidence and mortality in selected countries of Central Europe.
    Ondrusova M; Muzik J; Kliment J; Gulis G; Ondrus D
    Klin Onkol; 2011; 24(2):126-32. PubMed ID: 21638996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.